HPV Testing And Pap Test Market Size Worth $7.3 Billion By 2028

The global HPV Testing And Pap Test Market size is expected to reach USD 7.3 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 16.4% from 2021 to 2028. The introduction of innovative tests, increasing awareness programs, rising public-private investments, and high incidence of HPV infections are some of the factors anticipated to foster market growth during the forecast period.

Cervical cancer is a global problem, affecting millions of women. As per the Globocan estimates, in 2020, around 604,127 new cases of the cervix and uterine cancer were diagnosed globally, which led to around 341,831 deaths in the same year. According to the WHO, 99% of cervical cancer cases are linked with HPV infection. Such a high incidence and mortality rate of the disease has created a major demand for innovative and accurate screening for early detection and management. In addition, approval of novel testing solutions and services to upsurge screening rates is further anticipated to support market growth. In April 2020, Roche received FDA approval for its cobas HPV screening to be used on cobas 6800/8800 Systems, a fully automated and high-throughput system. Also, in February 2019, the Japanese company CMIC Healthcare Co., Ltd. launched SelCheck Cervical Cancer, a self-collect HPV test service focused on increasing the frequency of screening rates in the country.

The outbreak of novel coronavirus (COVID-19) and nationwide lockdowns due to it in key geographies has drastically reduced the routine cervical cancer screening procedures. According to data published by the CDC, due to stay-at-home orders, the cervical cancer screening rate decreased by around 80% in California, U.S. Thus, such decreased testing rates have negatively affected the overall revenue growth of the market in 2020. However, increasing government initiatives to control the reducing testing rates is anticipated to offset the impact of COVID-19 in the near future. For instance, in February 2021, NHS England initiated a trial and offered at-home HPV testing kits to more than 31,000 women to carry out screening in the privacy and convenience of their own homes. This trial aims to increase the HPV screening rate in the country.

Related Press Release@ HPV Testing And Pap Test Market Report

HPV Testing And Pap Test Market Report Highlights

• Based on test type, the Pap test segment accounted for the largest revenue share in 2020, owing to its widespread use in cervical cancer screening programs
• By application, the cervical cancer screening segment dominated the market in 2020, due to its higher incidence and mortality rates
• By product type, the consumables segment dominated the market in 2020, owing to its repetitive use to conduct testing in hospitals and laboratories
• The PCR segment is projected to show the fastest growth rate in the technology segment, owing to the enactment of new recommendations to use DNA HPV testing
• In Asia Pacific, the market is expected to witness lucrative growth as a result of the growing demand for HPV and Pap tests from emerging economies, such as China and India, which have a huge target population

List of Key Players of HPV Testing And Pap Test Market

• Abbott Laboratories
• Qiagen N.V.
• Becton, Dickinson and Company
• Quest Diagnostics, Inc.
• Hologic, Inc.
• F. Hoffmann-La Roche
• Femasys, Inc.
• Arbor Vita Corporation
• NURX, Inc.
• Seegene, Inc.
• Thermo Fisher Scientific, Inc.
• bioMérieux SA

Related Reports

HPV Associated Disorders Market

Cervical Cancer Diagnostic Market

HPV Testing And Pap Test Market Segmentation

Grand View Research has segmented the global HPV testing and Pap test market on the basis of test type, application, product, technology, end-use, and region:

HPV Testing & Pap Test Type Outlook (Revenue, USD Million, 2016 - 2028)

• HPV Testing
• Pap Test

HPV Testing & Pap Test Application Outlook (Revenue, USD Million, 2016 - 2028)

• Cervical Cancer Screening
• Vaginal Cancer Screening

HPV Testing & Pap Test Product Outlook (Revenue, USD Million, 2016 - 2028)

• Instruments
• Consumables
• Services

HPV Testing & Pap Test Technology Outlook (Revenue, USD Million, 2016 - 2028)

• PCR
• Immunodiagnostics
• Other Technologies

HPV Testing & Pap Test End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals & Clinics
• Laboratories
• Others

HPV Testing & Pap Test Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Asia Pacific
• Japan
• China
• India
• South Korea
• Australia
• Singapore
• Latin America
• Brazil
• Mexico
• Argentina
• MEA
• South Africa
• Saudi Arabia
• UAE

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-95196
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Pharmaceutical Contract Manufacturing And Research Services Market By Catalent; Pharmaceutical Product Development LLC; AbbVie; Baxter BioPharma Solutions

 

The global Pharmaceutical Contract Manufacturing And Research Services Market size is expected to reach USD 395.2 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.10% from 2023 to 2030. The rising investments in R&D, increasing demand for generics, and the growing aging population with various chronic diseases are responsible for market growth. However, the advent of COVID-19 led to a temporary shutdown of research and manufacturing activities of ancillary goods used for manufacturing drugs, which had impacted the supply chain and is likely to have a negative impact on the market growth.

Outsourcing allows pharmaceutical companies to focus on their core competencies such as sales and marketing rather than manufacturing and research. This is expected to have a positive impact on the market growth. However, the pharmaceutical companies practicing in-house manufacturing are increasing their investments with respect to production capabilities. This may limit the potential growth of contract manufacturing services to traditional customers, thereby hampering industrial growth.

The COVID-19 pandemic has provided new opportunities for pharmaceutical contract manufacturing and research services. Because of this pandemic, the contract service sector has switched its focus toward manufacturing and research of COVID-19 therapies and vaccines. For instance, in October 2020, CDMO Recipharm formed an agreement with Arcturus Therapeutics to support the manufacturing of its COVID-19 vaccine candidate—ARCT-021. Currently, it is in the phase 1/2 clinical trial. Similarly, in March 2022, the biotechnology company GeoVax partnered with a CRO CATO SMS to support GeoVAX in the Phase 2 trials of the COVID-19 Vaccine candidate GEO-CM04S1.

Related Press Release@ Pharmaceutical Contract Manufacturing And Research Services Market Report

List of Key Players of Pharmaceutical Contract Manufacturing And Research Services Market

• Catalent
• Pharmaceutical Product Development LLC
• AbbVie
• Baxter BioPharma Solutions
• Patheon
• Grifols International, S.A.
• Dalton Pharma Services
• Boehringer Ingelheim Biopharmaceuticals GmbH
• Lonza AG

 

Pharmaceutical Contract Manufacturing And Research Services Market Report Highlights

• By service, the manufacturing segment dominated the market in 2022. In this segment, Active Pharmaceutical Ingredient (API) / bulk drugs held the largest revenue share of over 60.0% in 2021. Pharmaceutical companies prefer outsourcing services for API research and manufacturing owing to the reduction in the cost of production of APIs
• In the manufacturing service segment, finished dose formulations are expected to register the fastest CAGR of 7.6% from 2023 to 2030
• The research service segment is further segmented based on therapeutic area, wherein oncology held a significant share of over 25.0% in 2021 and is anticipated to maintain its lead in the coming years owing to the high disease burden of cancer worldwide
• CMOs/CDMOs with the ability to establish facilities in emerging countries are expected to drive the market. The contract service sector is in its infancy in countries, including Brazil, India, and China
• Companies can position themselves for strong growth, given that demand is expected to expand rapidly in the coming years. Increased competitiveness in the contract service sector is anticipated to ultimately benefit the sector growth
• China, Japan, and India are projected to witness tremendous growth in the forecast period owing to high disease prevalence

Related Reports@
Europe Fill Finish Pharmaceutical Contract Manufacturing Market

Generic Pharmaceuticals Contract Manufacturing Market

Pharmaceutical Contract Manufacturing And Research Services Market Segmentation

Grand View Research has segmented the global pharmaceutical contract manufacturing and research services market based on service and region:

Pharmaceutical Contract Manufacturing And Research Service Outlook (Revenue, USD Billion, 2018 - 2030)

• Manufacturing
• API/Bulk Drugs
• Advanced Drug Delivery Formulations Packaging
• Packaging
• Finished Dose Formulations

• Solid Formulations
• Liquid Formulations
• Semi-solid Formulations
• Research
• Oncology
• Vaccines
• Inflammation & Immunology
• Cardiology
• Neuroscience
• Others

Pharmaceutical Contract Manufacturing and Research Services Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America
• U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• U.K.
• Denmark
• Sweden
• Norway
• Asia Pacific
• India
• China
• Japan
• Australia
• South Korea
• Thailand
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Chile
• Venezuela
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-95196
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Pen Needles Market Worth $7.7 Billion By 2030 | CAGR: 12.1%

The global Pen Needles Market size is expected to reach USD 7.7 billion by 2030, expanding at a CAGR of 12.1%, according to a new report by Grand View Research, Inc. Rising prevalence of diabetes is the primary reason for the significant growth of the industry. According to the International Diabetes Federation (IDF), nearly 537 million people were suffering from diabetes in 2021 across the globe. Such a high prevalence of diabetes has led to the rising demand for pen needles. Patients suffering from diabetes commonly use injectable pen devices, which help in easy drug delivery. In addition, obesity is a significant cause of diabetes. Obese people often suffer from type 2 diabetes, which makes them one of the highest revenue contributors to the target market.

Thus, people with type 2 diabetes are the common target population for companies manufacturing pen needles. Rising technological advancements are also expected to drive industry growth. Pen needles allow comfort and an easy mode of insulin delivery. These devices are technologically advanced and provide a superior alternative drug delivery method in comparison to syringes and vials. For instance, Becton, Dickinson, and Company launched BD Ultra-Fine Nano 4mm Pen Needles with EasyFlow Technology, which will enable diabetic patients to easily adhere to insulin therapy regimens. Europe dominated the global industry in 2021 followed by North America owing to the high prevalence of diabetes in the region. On the other hand, Asia Pacific is anticipated to exhibit the fastest growth rate during the forecast period owing to the rising awareness levels among the diabetic population regarding easy drug delivery.

Related Press Release@ Pen Needles Market Report

List of Key Players in the Pen Needles Market

·         Novo Nordisk A/S

·         Becton

·         Dickinson and Company

·         Terumo Corp.

·         Owen Mumford Ltd.

·         Ypsomed

·         B. Braun Melsungen AG

·         HTL-STREFA

·         UltiMed, Inc.

·         Allison Medical, Inc.

·         Artsana S.p.A.

Pen Needles Market Report Highlights

• The standard needles segment dominated the market in 2021 due to the availability of cost-effective needles as compared to safety needles
• Safety pen needles are anticipated to register the fastest CAGR during the forecast period due to the continuous technological advancements
• The 8mm needle length segment held the largest share in 2021 due to the convenience offered by these types to diabetic patients. The 4mm length segment is expected to witness the fastest CAGR during the forecast period
• Insulin therapy accounted for the largest market share in 2021 due to the rising awareness regarding self-administration of insulin among diabetic patients

Related Reports:
Diabetes Devices Market

Injection Pen Market

Pen Needles Market Segmentation

Grand View Research has segmented the global pen needles market on the basis of product, needle length, therapy, and region:

Pen Needles Product Outlook (Revenue, USD Million, 2018 - 2030)

• Standard Pen Needles
• Safety Pen Needles

Pen Needles Length Outlook (Revenue, USD Million, 2018 - 2030)

• 4 mm
• 5 mm
• 6 mm
• 8 mm
• 10 mm
• 12 mm

Pen Needles Therapy Outlook (Revenue, USD Million, 2018 - 2030)

• Insulin
• Glucagon-like-Peptide-1 (GLP-1)
• Growth Hormone

Pen Needles Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• Asia Pacific
• China
• India
• Latin America
• Brazil
• Mexico
• MEA
• South Africa

 

 About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Internet of Things in Healthcare Market – Industry Insights by Application and Technology

The global Internet Of Things In Healthcare Market size is expected to reach USD 861.3 billion by 2030 and is expected to expand at 16.8% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. High penetration of smartphones is one of the significant factors boosting the growth of the market. As per the statistics published in GSM Association’s report, The Mobile Economy 2018, the number of people connected to mobile services surpassed 5 billion in 2017 and the number of unique mobile subscribers is expected to reach 5.9 billion by 2030 (71% of the global population).

There is rising awareness among people for self-health monitoring and diagnosis due to the increase in the burden of various health issues at the early component of life. Rising awareness regarding healthy lifestyles among the young and adult population to adopt smart wearables to remotely monitor health activities and track them and monitor health issues is driving the market growth. Furthermore, many companies and healthcare institutions are launching mHealth programs for remote patient monitoring, which is leading to an increase in the adoption of IoT solutions for remote patient monitoring services.

Technological advancements in healthcare IT infrastructure, including the use of IoT, AI, and big data are one of the key factors boosting the market growth. Moreover, the growing demand for efficient & effective treatment and increasing awareness among patients about upgraded technology are also some of the factors expected to boost the internet of things in the healthcare market over the forecast period. Advanced technologies, such as smart sensors, robotic pills, microcontroller, digital networking, automotive microcontrollers, radiofrequency, and sensors, play a significant role in driving the market.

Rise in healthcare spending across the globe is driving the demand for the implementation of IoT solutions in the healthcare sector. According to estimates published by WHO in 2020, global spending on healthcare witnessed a significant surge, accounting for 11% of the global GDP or USD 9 trillion. The healthcare industry is evolving from fee-for-service model to value-based model, wherein treatment outcomes are reimbursed. The pressure of reducing healthcare costs is escalating globally as its cost is increasing faster than the growth of economies.

Furthermore, IoT solutions-enabled clinical trials also offer an opportunity for cost reduction as IoT simplifies the overall process and captures sophisticated endpoints. Remote patient monitoring solutions help in handling of noncritical patients at home, which eventually reduces hospital admissions and improves workflow efficiency. In addition, IoT solutions also enhance clinical operations through asset tracking and improvement in data capturing helping in significant cost savings. Thus, the demand for the development of the internet of things in healthcare is rising globally.

Related Press Release@ Internet of Things in Healthcare Market Report

Internet of Things in Healthcare Market Report Highlights

• Medical devices segment held the largest share of 2022 owing to the growing demand for self-monitoring devices and the launch of novel instruments. For instance, in March 2022, Amrita University introduced Amrita Spandanam, a wearable non-prick health monitoring device that can monitor blood pressure and measure blood glucose without pressure cuffs
• By connectivity technology, the cellular network segment accounted for the largest share in 2022. This can be attributed to the benefits of cellular network including increased capacity, less power consumption, and reduced interference
• By application, telemedicine segment dominated the market in 2022 owing to the increasing number of patients suffering from conditions requiring Long-Term Care (LTC), including Alzheimer’s disease, cancer, diabetes, and cardiovascular diseases
• Based on end-use, hospitals and clinics segment dominated the market in 2022. Rising investments by hospitals for accelerating the adoption of IoT solutions is a key factor propelling the segment growth
• Due to the rising adoption of electronic health records, increasing government support for internet of things in healthcare and growing usage of e-prescribing, telehealth, and other HC IT technologies in North America, the region had the largest market share

List of Key Players in the IoT in Healthcare Market

·         Medtronic

·         Cisco Systems, Inc.

·         IBM Corporation

·         GE Healthcare

·         Microsoft Corporation

·         SAP SE

·         Infosys Limited

·         Cerner Corporation

·         QUALCOMM Incorporated

·         Amazon

·         Intel Corporation

·         Wipro ltd

Related Reports:
Electronic Health Records Market

Telehealth Market

Internet of Things in Healthcare Market Segmentation

Grand view research has segmented the global internet of things in the healthcare market based on component, connectivity technology, application, end-use, and region:

IoT in Healthcare Component Outlook (Revenue, USD Million, 2018 - 2030)

·         Medical Devices

o    Wearable External Devices

o    Implanted Medical Devices

o    Stationary Medical Devices

·         System and Software

o    Remote Device Management

o    Network Bandwidth Management

o    Data Analytics

o    Application Security

o    Network Security

·         Services

o    System Integration Services

o    Consulting, Training, and Education

o    Support and Maintenance Services

IoT in Healthcare Connectivity Technology Outlook (Revenue, USD Million, 2018 - 2030)

·         Cellular

·         Wi-Fi

·         Bluetooth

·         LPWANs

·         Zigbee

·         RFID

IoT in Healthcare Application Outlook (Revenue, USD Million, 2018 - 2030)

·         Telemedicine

·         Patient Monitoring

·         Connected Imaging

·         Clinical Operations

·         Medical Management

·         Others

IoT in Healthcare End-use Outlook (Revenue, USD Million, 2018 - 2030)

·         Hospitals and Clinics

·         Clinical Research Organizations

·         Research and Diagnostic Laboratories

·         Others

IoT in Healthcare Regional Outlook (Revenue, USD Million, 2018 - 2030)

·         North America

o    U.S.

o    Canada

·         Europe

o    U.K.

o    Germany

o    France

o    Italy

o    Spain

o    Sweden

o    Norway

o    Denmark

·         Asia Pacific

o    Japan

o    China

o    India

o    South Korea

o    Australia

o    Thailand

·         Latin America

o    Brazil

o    Mexico

o    Argentina

·         MEA

o    South Africa

o    Saudi Arabia

o    UAE

o    Kuwait

 

 About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com